# AMTIXBIO CO.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amtixbio-co

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.amtixbio.com
- Total disclosed funding: $18M
- Latest round: Series C (Jun 30, 2021)
- Investors on record: 15

## About

Based in Seoul, South Korea, and founded in 2015 by founder Jong Seung Lee, AmtixBio Corp. is a developer of antifungal drugs that treat infectious diseases caused by fungi, such as athlete's foot. In June 2021, AmtixBio Corp. raised KRW 20 billion in series C funding from investors Holistic Growth Initiative, KDB Capital, QUAD Ventures, Simone Investment, and UbiQuoss Investment, with participation from investor Shinhan Venture Investment.

AmtixBio Corp. offers solutions to treat antifungal diseases, such as microbial infectious diseases, fungus infections, bacterial infections, inflammatory disorders, and more. The company's product portfolio includes ATB1651: Treatments for onychomycosis and cutaneous mycosis; ATB6023: meningitis and pulmonary fungus infection treatment; ATB 60XX Series: treatment of multidrug-resistant fungal infections and hairy fungal infections; ATB1606: anti-inflammatory drugs; and HA-ATB: biocompatible materials.

## Funding rounds

- Series C, Jun 30, 2021, $18M — Shinhan Venture Investment, KDB Capital, Shinhan Capital, NH Investment & Securities, Samsung Securities, Holistic Growth Initiative, QUAD Ventures, QuantaMatrix Inc., UbiQuoss Investment, Simone Investment, Solid Private Equity, Hans Corporation, Oda Stone Partners
- Series B, Dec 1, 2018 — SBI Investment Korea, Korea Investment & Securities, Shinhan Venture Investment

## Investors

- SBI Investment Korea (https://capitalatlas.ai/funds/sbi-investment-korea) — Series B
- Korea Investment & Securities (https://capitalatlas.ai/funds/korea-investment-securities) — Series B
- Shinhan Venture Investment (https://capitalatlas.ai/funds/shinhan-venture-investment) — Series B, Series C
- KDB Capital (https://capitalatlas.ai/funds/kdb-capital) — Series C
- Shinhan Capital (https://capitalatlas.ai/funds/shinhan-capital) — Series C
- NH Investment & Securities (https://capitalatlas.ai/funds/nh-investment-securities) — Series C
- Samsung Securities — Series C
- Holistic Growth Initiative (https://capitalatlas.ai/funds/holistic-growth-initiative) — Series C
- QUAD Ventures (https://capitalatlas.ai/funds/quad-ventures) — Series C
- QuantaMatrix Inc. — Series C
- UbiQuoss Investment (https://capitalatlas.ai/funds/ubiquoss-investment) — Series C
- Simone Investment — Series C
- Solid Private Equity (https://capitalatlas.ai/funds/solid-private-equity) — Series C
- Hans Corporation — Series C
- Oda Stone Partners — Series C